Navigation Links
Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2010
Date:2/1/2011

0$2,413Worldwide coronary stent system net sales for the full year - on a reported basis - were as follows: (in millions)U.S.InternationalWorldwide201020092010200920102009   Drug-eluting stent systems$

805$

911$

732$

797$

1,537$

1,708   Bare-metal stent systems445789114133171Total coronary stent systems$849$968$821$911$1,670$1,879On a GAAP basis, net loss for the full year 2010 was $1.065 billion, or $0.70 per share, and was driven primarily by a goodwill impairment charge recorded in the first quarter of 2010.  Reported results included goodwill and intangible asset impairment charges; acquisition-, divestiture-, litigation- and restructuring-related net charges; discrete tax items and amortization expense (after-tax) of $2.116 billion, or $1.39 per share, which consisted primarily of:

  • $1.817 billion (on both a pre-tax and after-tax basis) of goodwill impairment charges associated with the Company's U.S. CRM business unit;
  • $55 million ($65 million pre-tax) of intangible asset impairment charges;
  • $211 million ($245 million pre-tax) of acquisition-related net credits, consisting of a gain related to the receipt of an acquisition-related milestone payment from Abbott Laboratories; as well as due diligence and other fees, an inventory step-up adjustment and contingent consideration expense related to 2010 acquisitions;
  • a $77 million ($104 million pre-tax) gain associated with the settlement of a litigation matter with Medinol, Ltd.;
  • $121 million ($169 million pre-tax) of restructuring and restructuring-related net charges associated with the Company's 2010 Restructuring plan, Plant Network Optimization program and 2007 Restructuring plan;
  • $11 million of discrete tax items related to certain tax positions taken in a prior period; and
  • $420 million ($513 million pre-tax) of amortization expense.

    • Adjusted net income for the full year 2010, ex
    '/>"/>

    SOURCE Boston Scientific Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

    Related medicine technology :

    1. Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System
    2. Boston Scientific Responds to DOJ Civil Lawsuit
    3. Boston Scientific Announces First Use of Blazer® Open-Irrigated Catheter in U.S.
    4. Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Element™ Everolimus-Eluting Stent
    5. Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent
    6. Boston Scientific Announces Agreement With Fukuda Denshi for Distribution of Cardiac Rhythm Management Products in Japan
    7. Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and Full Year 2010 Financial Results
    8. Boston Scientific to Acquire Atritech
    9. Boston Scientific Completes Enrollment in Clinical Trial Evaluating Next-Generation Nitinol Stent to Treat Iliac Artery Disease
    10. Statement of Kenneth Stein, M.D., Chief Medical Officer, Cardiac Rhythm Management, Boston Scientific on JAMA Article
    11. Boston Scientific Completes Acquisition of Sadra Medical
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/16/2013)... 2013  Nektar Therapeutics, (Nasdaq: NKTR ) President ... , is scheduled to present at the upcoming 2013 UBS ... at the Sheraton New York Hotel on Tuesday, May 21, ... will be accessible via a Webcast through a link posted ... website: http://www.nektar.com . This Webcast will be available for ...
    (Date:5/16/2013)... Mass. , May 16, 2013  Alere Inc. (NYSE: ... to take charge of their health at home through the ... cash dividend of $3.00 per share on its Series B ... on July 15, 2013 to holders of record of Series ... 2013.  Such payment will cover the amount of ...
    (Date:5/16/2013)... , May 16, 2013 OrthoView ... the U.S. to access the widely-used OrthoView digital templating ... and Internet connection to get started. OrthoView, ... for over 10 years, is dedicated to enabling orthopaedic ... digital x-ray images, when printed film is unavailable. Over ...
    Breaking Medicine Technology:Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons 2
    ... Nile Therapeutics,Inc. (Nasdaq: NLTX ), today announced ... placebo-controlled clinical study of CD-NP, a novel,chimeric natriuretic ... heart failure., The primary objective of the ... physiologic parameters of intravenous infusions of,CD-NP in patients ...
    ... Transplant Monitoring Test that Meets International Standards for ... ... The ability of blood,tests to precisely measure very low doses ... difference in assuring long-term,viability and survival, according to research presented ...
    Cached Medicine Technology:Nile Therapeutics Announces Dosing in Second Phase Ib Study of CD-NP in Heart Failure Patients 2Nile Therapeutics Announces Dosing in Second Phase Ib Study of CD-NP in Heart Failure Patients 3Precise Low-Dose Drug Monitoring Essential for Long-Term Kidney Transplant Success 2Precise Low-Dose Drug Monitoring Essential for Long-Term Kidney Transplant Success 3
    (Date:5/19/2013)... Passages Malibu, the leading non-12 step, ... this week the launch of a “Sobriety, Health, and ... channels. “We are always looking for new ways ... get feedback regarding sobriety, what’s working for people, and ... the Passages Addiction Treatment Centers located in ...
    (Date:5/19/2013)... May 19, 2013 The AMTC team will ... the Columbus Georgia Convention & Trade Center on June 1st. ... attend. AMTC auditions are free of charge. , Actors, Models ... for hundreds of successful artists and grads like Caitlin Kinney ... European Tombolini , Chris Young - on his Liquid Neon ...
    (Date:5/19/2013)... The legal team at Pulaski & Middleman, ... effort to connect women and families coping with the ... Yasmin & Ocella with the legal representation they need. ... notorious birth control drugs as well as news and ... Yasmin & Ocella were very popular birth control medications ...
    (Date:5/18/2013)... COOLA, British Columbia (PRWEB) May 19, 2013 ... to Cooking” (published by iUniverse) , author Janet Hall Svisdahl’s ... delectable world recipes sure to make even the pickiest ... living peacefully, pleasurably and prayerfully,” she explains. , Found ... Spirit” are a wide range of delicious recipes, from fast ...
    (Date:5/18/2013)... Each year, the American Gastroenterological Association (AGA) ... achievements in gastroenterology through its esteemed recognition awards. ... talented individuals who work tirelessly to advance the ... pleased to announce the 2013 recognition award honorees ... their tremendous contributions to our field," said Loren ...
    Breaking Medicine News(10 mins):Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2Health News:Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers 2Health News:Janet Hall Svisdahl Announces Release of ‘Cooking with Spirits for the Spirit’ 2Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 2Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 3Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 4Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 5
    ... in to Boston from India, on April 26, brought over ... the 18th floor of the John Hancock Tower, little did ... ,On May 5 the characteristic symptoms of measles ... measles struck another half-dozen workers at Investors Bank & Trust, ...
    ... at new prescription- only medicines that were publicly funded between 2000 ... new prescription-only medicines have been listed on the Australian PBS, ... are registered in New Zealand, of which only 20 are ... New Zealand is slower to fund new drugs when compared ...
    ... the Queensland Department of Primary Industries (DPI) has quarantined ... ,Although the DPI has not yet confirmed what ... could be serious.,The general manager of plant biosecurity, Chris ... trace-back and trace-forward process and would also begin surveillance ...
    ... has provided $7 million towards development of some of ... //. ,According to the incoming president of ... beds and acute care beds would help to provide ... opinions differ, with Dr. Margaret MacDiarmid hoping that new ...
    ... According to the doctors at Kozhikode Medical College Hospital, Kerala ... //. ,The man named Akkooppoyil Achuthan aged 65 ... six Kg tumor. ,Then he was discharged but ... an X-ray another doctor found the scissors in the stomach. ...
    ... of the gene responsible for Type 2 diabetes scientists have ... //. ,The PSARL gene associated with the Type ... in Washington tomorrow. ,Diabetes, now considered as an ... about $3 billion annually. ,Diabetes has long been ...
    Cached Medicine News:Health News:Global Threat of Measles Outbreak 2
    ... Stabilizer Plastazote® with plastic anterior ... straps. Chin cradle reduces rotation. ... be interchanged for individualized fitting.,Philadelphia™ ... standard Philadelphia Collar for added ...
    Bougie Urethrotomes for slitting the female urethra and for meatus stenosis in males...
    Optical Mini Urethrotome for telescope 3.3 mm, 0...
    ... cystoscope is being used more and more as ... outstanding optical quality and large working/irrigation channel, the ... therapy. The outstanding flexibility of the cystoscope guarantees ... Being simple ...
    Medicine Products: